Table 2.
Response | Cohort 1 (n=9) |
Cohort 2 (n=20) |
Total (N=29) |
---|---|---|---|
Complete response (CR), n (%) | 0 | 2 (10) | 2 (7) |
Partial response (PR), n (%) | 4 (44) | 7 (35) | 11 (38) |
Stable disease (SD), n (%) | 5 (56) | 11 (55) | 16 (55) |
Clinical benefit rate (CR + PR + SD), n (%) | 9 (100) | 20 (100) | 29 (100) |
Abbreviation: RECIST, Response Evaluation Criteria in Solid Tumors.